Pine Valley Investments Ltd Liability Co Increases Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Pine Valley Investments Ltd Liability Co grew its stake in IQVIA Holdings Inc. (NYSE:IQV) by 0.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,481 shares of the medical research company’s stock after buying an additional 50 shares during the period. Pine Valley Investments Ltd Liability Co’s holdings in IQVIA were worth $2,247,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the stock. Canada Pension Plan Investment Board boosted its stake in IQVIA by 6.6% in the second quarter. Canada Pension Plan Investment Board now owns 3,403,488 shares of the medical research company’s stock valued at $719,634,000 after acquiring an additional 211,653 shares in the last quarter. Farallon Capital Management LLC lifted its stake in IQVIA by 3.1% in the second quarter. Farallon Capital Management LLC now owns 2,923,032 shares of the medical research company’s stock valued at $618,046,000 after buying an additional 86,870 shares during the last quarter. FMR LLC boosted its holdings in shares of IQVIA by 38.7% in the third quarter. FMR LLC now owns 2,887,342 shares of the medical research company’s stock valued at $684,213,000 after acquiring an additional 804,963 shares during the period. Impax Asset Management Group plc grew its position in shares of IQVIA by 9.7% during the third quarter. Impax Asset Management Group plc now owns 1,793,010 shares of the medical research company’s stock worth $423,885,000 after acquiring an additional 157,809 shares during the last quarter. Finally, Legal & General Group Plc increased its holdings in shares of IQVIA by 0.8% in the 2nd quarter. Legal & General Group Plc now owns 1,514,237 shares of the medical research company’s stock valued at $320,170,000 after acquiring an additional 11,715 shares during the period. 89.62% of the stock is owned by hedge funds and other institutional investors.

IQVIA Stock Performance

NYSE IQV opened at $200.37 on Friday. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. The stock has a market cap of $36.37 billion, a price-to-earnings ratio of 26.30, a price-to-earnings-growth ratio of 2.07 and a beta of 1.49. IQVIA Holdings Inc. has a fifty-two week low of $187.62 and a fifty-two week high of $261.73. The business has a fifty day moving average of $213.40 and a 200-day moving average of $224.61.

Analysts Set New Price Targets

A number of research firms recently issued reports on IQV. Royal Bank of Canada reissued an “outperform” rating and set a $270.00 price target on shares of IQVIA in a report on Wednesday. Truist Financial dropped their target price on IQVIA from $265.00 to $261.00 and set a “buy” rating on the stock in a report on Thursday. StockNews.com downgraded IQVIA from a “buy” rating to a “hold” rating in a report on Thursday, November 28th. Leerink Partners restated an “outperform” rating and set a $248.00 price objective (down previously from $260.00) on shares of IQVIA in a research report on Tuesday, November 19th. Finally, Robert W. Baird dropped their price target on shares of IQVIA from $213.00 to $212.00 and set a “neutral” rating on the stock in a research note on Wednesday. Four investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $257.60.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.